HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$2.42
Day range
$2.27 - $2.43
Year range
$1.64 - $12.50
Market cap
821.41M USD
Avg Volume
13.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 59.95M | 92.73% |
Operating expense | 117.06M | 15.16% |
Net income | -111.66M | -14.99% |
Net profit margin | -186.25 | 40.34% |
Earnings per share | -0.33 | 2.94% |
EBITDA | -104.71M | -12.06% |
Effective tax rate | -1.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 301.18M | -26.99% |
Total assets | 907.44M | -5.90% |
Total liabilities | 208.95M | 6.73% |
Total equity | 698.49M | — |
Shares outstanding | 361.85M | — |
Price to book | 1.19 | — |
Return on assets | -30.35% | — |
Return on capital | -36.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -111.66M | -14.99% |
Cash from operations | -67.45M | 31.48% |
Cash from investing | 13.84M | -65.58% |
Cash from financing | 13.23M | -91.34% |
Net change in cash | -39.64M | -141.95% |
Free cash flow | -12.18M | 77.07% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
838
